Perioperative Immune Therapy

Study identifies biomarkers linked to better outcomes from perioperative immunotherapy in lung cancer

Researchers report findings on biological markers that correlate with improved patient outcomes when immune-based therapies are used before and after surgery for lung cancer. The publication, appearing on Nature's platform, outlines how certain biomarkers may help predict which patients respond best to this perioperative treatment approach.